OLIPASS Corporation (KOSDAQ:244460)
South Korea · Delayed Price · Currency is KRW 1,651.00
-267.00 (-13.92%)
At close: Apr 7, 2025
OLIPASS Market Cap
OLIPASS has a market cap or net worth of 8.4 billion as of November 13, 2026. It is the 43,730th most valuable company in the world and the 2,662nd biggest in South Korea. Its market cap has decreased by 58.37% in one year.
Market Cap
8.40B
Enterprise Value
7.93B
Revenue
5.25B
Global Rank
Country Rank
#2,662 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since September 20, 2019, OLIPASS's market cap has decreased from 344.12B to 8.40B, a decrease of -97.56%. That is a compound annual growth rate of -48.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2025 | 8.40B | -63.10% |
| Dec 30, 2024 | 22.77B | -14.18% |
| Dec 28, 2023 | 26.53B | -85.86% |
| Dec 29, 2022 | 187.57B | -21.32% |
| Dec 30, 2021 | 238.38B | -46.89% |
| Dec 30, 2020 | 448.87B | 20.23% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Progen | 27.68B |
| Epibiotech | 22.01B |
| ADBiotech | 20.81B |
| Poongjeon Pharmacy CO.,LTD. | 20.55B |
| Shaperon | 19.01B |
| Moogene Medi | 18.89B |
| Plumbline Life Sciences | 18.69B |
| NGeneBio | 13.35B |